Company Overview
Snapshot
Founded in October 2011 by Daniel Levitt and Oren Milstein, PhD, StemRad operates with 11–50 employees. The company has raised $7.81M across four funding rounds from investors Jeff Vinik and Wanaka Capital Partners. In December 2023, StemRad secured a $4.5 million contract to provide radiation shielding for US troops.
Business overview
StemRad develops personal radiation-protection solutions for various sectors, including first responders, military personnel, utility workers, medical teams, and astronauts. Its core technology includes the 360 Gamma, a wearable shield designed to protect critical radiosensitive organs from gamma radiation, and AstroRad, personal protective equipment co-developed with Lockheed Martin for astronauts in deep space, which also protects organs vulnerable to cancer from chronic radiation exposure. The company operates in the Aerospace, Defense & HLS sector, serving industrial manufacturing, defense, safety & security, energy, utilities & waste management, and healthcare & life sciences markets.
Strategic signal
In December 2023, StemRad secured a significant $4.5 million contract to provide gamma radiation shielding for US troops. This contract signals strong market validation for StemRad's protective technology within the defense sector and indicates a growing demand for advanced personal radiation safety solutions for military applications, positioning the company for further expansion in critical defense and security markets.
Log in to access full profile ›Company Intelligence Q&A
- What was a key recent commercial achievement for StemRad?
- In December 2023, StemRad secured a $4.5 million contract to supply its gamma radiation shielding technology to US troops.
- Which partners were involved in testing StemRad's AstroRad technology on NASA's Artemis I mission?
- In December 2022, StemRad tested its AstroRad technology on NASA's Artemis I mission, partnering with Lockheed Martin and the Israel Space Agency.
- What was the purpose of the AstroRad vest's deployment to the International Space Station?
- In October 2019, StemRad's AstroRad vest was launched to the International Space Station in collaboration with the Israeli Space Agency to gather feedback on its performance and conduct ergonomic studies in microgravity.
- What was the focus of StemRad's expansion in February 2020?
- In February 2020, StemRad expanded its product line to include the StemRad MD, an exoskeleton designed to protect healthcare providers from harmful radiation exposure, with plans for US manufacturing.
- Which investor participated in a funding round for StemRad in December 2017?
- In December 2017, Jeff Vinik invested in StemRad, which enabled the company to expand its sales, marketing, and manufacturing capabilities in the United States.